empagliflozin/linagliptin/metformin extended release (FDC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for empagliflozin/linagliptin/metformin extended release (FDC), covering 2020-02-21 to 2020-02-21. Get the full timeline:
Most recent: Clinical Trial Update: Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets [Phase 1]